Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 53.32%.However, over the last six months, we can see a weaker performance of 13.91%. Over the last 30 days, the price of HUMA has leaped by -22.79%. And in the last five days, it has fallen by -14.64%.
Humacyte Inc. (HUMA) currently has a stock price of $3.23. The stock saw a sharp increase in the last trading session, hitting a high of $3.615 after opening at $3.55. The lowest recorded price for the day was $3.23 before it closed at $3.54.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Humacyte Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $5.60 on 05/08/23, and the lowest price during that time was $1.96, recorded on 12/30/22.
52-week price history of HUMA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Humacyte Inc.’s current trading price is -42.23% away from its 52-week high, while its distance from the 52-week low is 65.05%. The stock’s price range for this period has been between $1.96 and $5.60. The Healthcare sector company’s shares saw a trading volume of about 1.72 million for the day, which was higher than the average daily volume of 0.7 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Humacyte Inc. (HUMA) has experienced a quarterly decline of -3.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 366.20M and boasts a workforce of 164 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.53, with a change in price of -0.17. Similarly, Humacyte Inc. recorded 601,965 in trading volume during the last 100 days, posting a change of -4.85%.
HUMA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for HUMA stands at 0.33. Similarly, the long-term debt-to-equity ratio is also 0.29.
HUMA Stock Stochastic Average
As of today, the raw stochastic average of Humacyte Inc. over the last 50 days is at 25.31%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 1.42%. Further, the company’s Stochastic %K and %D values for the last 20 days were 25.23% and 34.74%, respectively.
